Chattem, INC D/B/A Opella
Healthcare related to nonprescription drugs and dietary supplements.
Based in NJ
AI Overview
With $730K in lobbying spend across 5 quarterly filings, Chattem, INC D/B/A Opella is an active lobbying client. Their lobbying covers 4 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $730K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Chattem, INC D/B/A Opella disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation, Trade, Consumer Issues
Healthcare policy for non-prescription drugs and dietary supplements, tax and trade.
Non-prescription drug issues. Monograph reauthorization. Rx to OTC switch. HSA/FSA.
Regulatory pathways for OTC drugs and dietary supplements, including OMUFA and Rx to OTC switch.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.